MASIMO CORPORATION

Lobbying for MASIMO CORPORATION

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $100,000.00 expenses · posted Apr 21, 2025

Lobbying activity 2

Health Issues

Support of legislation to mandate continuous monitoring for patients taking opioids; Patient safety policy and legislation; Remote patient monitoring technology and telehealth Medicare coverage

Tariff (miscellaneous tariff bills)

Issues related to increased tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.